CIK 0000749647 · Non-accelerated filer<br>Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521256615
- Phone
- (609) 896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,942
- in 2 filings
Net −$7,942. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-06 | Braun Donald P Director | Grant or award · Option to purchase Imunon common stock | +9,072 | 28,905 | ||
| 2024-09-06 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +4,964 | 23,630 | ||
| 2024-09-06 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +3,634 | 17,301 | ||
| 2024-09-06 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +6,737 | 32,070 | ||
| 2024-09-06 | Lindborg Stacy President and CEO | Grant or award · Stock Option (Right to Buy) | +63,602 | 302,768 | ||
| 2024-09-06 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +82,926 | 394,759 | ||
| 2024-09-06 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +40,653 | 173,486 | ||
| 2024-08-20 | Braun Donald P Director | Purchase | +25,000 | $1.18 | $29K | 25,597 |
| 2024-08-15 | Lindborg Stacy President and CEO | Purchase | +25,000 | $0.98 | $25K | 264,166 |
| 2024-08-15 | Tardugno Michael H Executive Chairman of Board | Purchase | +25,000 | $1.03 | $26K | 353,346 |
| 2024-06-12 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +100,000 | 328,346 | ||
| 2024-06-12 | Lindborg Stacy President and CEO | Grant or award · Stock Option (Right to Buy) | +112,500 | 239,166 | ||
| 2024-06-12 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 135,688 | ||
| 2024-06-12 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 37,099 | ||
| 2024-06-12 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 18,666 | ||
| 2024-06-12 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 13,667 | ||
| 2024-06-12 | Braun Donald P Director | Grant or award · Option to purchase Imunon common stock | +3,500 | 23,430 | ||
| 2024-05-13 | Lindborg Stacy President and CEO | Grant or award · Stock Option (Right to Buy) | +112,500 | 126,666 | ||
| 2024-03-14 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 6 of 6 · 119 trades